|
Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease — an often-fatal condition in fetuses and newborns that is now exceedingly rare in the United States and Western Europe — actually receive it, finds a study led by researchers at Vagelos College of Physicians and Surgeons at Columbia University Irving Medical Center.
|